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INTRODUCTION 
The main goal of this study was to evaluate the diagnostic and 
prognostic significance of serum prolactin concentration in cirrhosis in 
determining the severity of hepatic disease and its correlation with CHILD 
PUGH score. 
Prolactin secretion follows a pulsatile pattern with characterisitic 
nocturnal rise. In patient with cirrhosis , associated with elevated 24 hours 
prolactin level and loss of circadian rhythm. Increased level of serum prolactin 
associated with increased risk of hepatic encephalopathy and progression of 
severity of hepatic disease. 
Patients with end-stage liver disease have several endocrine 
dysfunctions, which include alterations in the functioning of the hypothalamic-
pituitary-gonadal axis and the serum levels of sex hormones.  
Our prospective study showed that cirrhotic men have significant 
alterations in the pituitary regulatory functions, and that these disorders are 
completely reversed after liver transplantation. In cirrhosis, excess production 
of SHBG in liver and increased prolactin levels were detected while exploring 
the cause of gynecomastia and high level of liver estrogen receptors was added 
to the direct suppressing effect of estrogen on Leydig cell functions [5].  
 Decompensated liver function leads to an alteration in the type of amino 
acids entering the central nervous system. Circulating concentrations of 
aromatic amino acids have been found to increase leading to an increase in the 
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synthesis of false neurotransmitters such as octopamine and 
phenylethanolamine.[8] These false neurotransmitters may inhibit the 
dopamine release contributing to hyperprolactinemia. Cases of hypogonadism 
have also been reported in patients with cirrhosis attributing to 
hyperprolactinemia.[9]  A similar correlation of mortality to serum prolactin 
levels was observed by McClain et al.[10] and Sharma et al.[11] with a higher 
risk of mortality with serum prolactin values of >50 ng/ml. Mukherjee et 
al.[12] analyzed the prolactin levels in patients with hepatic cirrhosis and found 
a higher levels in both patients with encephalopathy and mortality.Patient with 
liver cirrhosis complicated by hepatic encephalopathy found to have low serum 
total T3, serum cortisol and high prolactin level. These are early indicators of 
impending hepatic encephalopathy and progression of liver disease.Serum 
prolactin was found to be elevated in 39 to 75 percent cirrhotic patients.  
CHILD PUGH SCORING SYSTEM: 
 Cirrhosis can be staged clinically. A reliable scoring system is the 
modified CHILD PUGH scoring system. It ranges from 5 to 15.  
 Child Pugh CLASS A : Score of 5 and 6 , consistent with compensated 
cirrhosis. 
 Child Pugh CLASS B : Score of 7 to 9 , consistent with decompensated 
cirrhosis. 
 Child Pugh CLASS C :Score more than 10 , consistent with 
decompensated cirrhosis. 
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This scoring system includes 5 factors : serum bilirubin, serum albumin, 
ascites, hepatic encephalopathy and prothrombin time. It is reasonably a 
reliable predictor of survival and predicts the likelihood of major complications 
like bleeding from the varices and spontaneous bacterial peritonitis.It was also 
used to assess the prognosis in cirrhosis and to provide a standard criteria in 
listing the patient for liver transplantation. 
 Thus comparing the serum prolactin level with the Child pugh scoring 
system in assessing the severity of the liver disease and predicting the risk of 
complications. 
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AIM OF THE STUDY 
 
PRIMARY AIM 
1. To study the prevalence of hyper prolactinemia in cirrhosis. 
2. To assess the relation between serum prolactin levels and disease 
severity, predicting complications in patients with cirrhosis. 
3. To compare the efficacy of serum prolactin to that of child pugh scoring 
system in cirrhosis 
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REVIEW OF LITREATURE 
CIRRHOSIS 
 ―Cirrhosis is an irreversible liver disease with definable pathological 
changes are chronic damage of the hepatocytes which is not reversible, .fibrosis 
of the liver distorting the architecture and reactive nodular regeneration 
Cirrhosis is defined ―anatomically as a diffuse process with fibrosis and 
nodule formation‖. The hallmark pathological feature is   extreme damage to 
the hepatocytes followed by replacement of liver tissue by fibrosis with nodule 
formation. This is mainly due to necrosis of hepatocytes, loss of reticular 
network &regeneration of remaining liver tissue by nodules. 
Micro-nodular cirrhosis becomes macro-nodular cirrhosis with absence 
of hepatic inflammation and necrosis. Portal fibrosis is seen in alcoholic liver 
disease.‖  
PATHOGENESIS 
  ―The liver damage leads to activation of stellate cells in the space of 
disse. The stellate cells are activated cytokines which are primarily produced 
by hepatocytes, tissue machrophage (kupffer cells),lymphocytes and 
megakaryocytes. The cascade of events following stellate cell activation mainly 
by selfstimulation leading to synthesis of platelet derived growth factor, 
transforming growth factor beta1.these stellate cells produce collagen matrix 
and substance that inhibit the breakdown of collagen. The substance that inhibit 
collagen breakdown are mettalloproteinases 2 and 9 are inturn stimulated by 
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TIMP 1 and TIMP2,the other cytokines produced are T helper 2 lymphocytes-
IL 6 and 13. 
                 Similarly clinical manifestation often are due to alteration in the 
morphology and this correlates with severity of damage to the hepatocyte 
rather with the etiology of the liver disease. 
                Distortion of functional hepatocyte may cause icterus, coagulation 
abnormalities, vascular disturbances due to fibrosis(portal hypertension) and its 
complications-oesophageal  varies and splenomegaly. both portal hypertension 
and hepatocellular damage cause ascites and hepatic encephalopathy. 
               Micronodular cirrhosis is characterized by ―thick,regular septa, with 
regenerating small nodules varying little in size, and involvement of every 
lobule. May represent impaired capacity for regrowth as in alcoholism, 
malnutrition,old age and anaemia. 
               Macronodular cirrhosis is characterized by ―septae and nodules of 
variable sizes and by normal lobules in larger nodules. Previous collapse is 
shown by juxtaposition of three or more portal tracts in the fibrous scars. 
Regeneration is reflected by large cells with large nuclei and by cell plates of 
varying thickness. With time macronodular converts to micronodular.‖ 
ALCOHOL AND LIVER: 
 A strong correlation between Alcohol and cirrhosis was found out by 
Mathew Baillie in 1793. It is one of the rising cause of death worldwide. 
Metabolism of Alcohol: 
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  Alcohol is absorbed in the duodenum and  upper part of  jejunum 
by simple diffusion,which is delayed following a meal and increased 
according to the concentration of the alcohol drank. The peak level of 
alcohol in blood reached after 20 minutes from the time of consumption. 
The absorption depends on the blood flow, and it is poorly soluble in 
lipids ;  leading to prolonged effect in females. 
  Alcohol cannot be stored in the body for a long time, it has to 
undergo oxidation to acetaldehyde by acetaldehyde dehydrogenase;  the 
acetaldehyde forms complex with proteins to form protein adducts 
which is responsible for most of the symptoms related to alcohol liver 
injury. 
  Alcohol induces its own metabolism. The alternate pathway for 
alcohol metabolism is Microsomal ethanol oxidizing system involving 
cytochrome P4502E1. Alcohol induces CYP2E1 leading to 
hepatotoxicity of other drugs.eg Paracetamol. 
   ―Acetaldehyde is a potent hepatotoxic which is responsible for 
flushing in alcoholics. It affects liver by several mechanisms.  
1. Induction of steatosis more common in the zone 3, by alteration of 
redox potential. 
2. It increases the sensitization of TNF alpha  which leads to hepatic 
necrosis. 
3. It is extremely reactive and toxic; it binds to phospholipids ,amino 
acid residues and reactive groups in the enzyme. 
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4. It helps in the emergence of new antigens to the surface. 
5. It depolymerizes the protein structure and affects the normal folding 
of the proteins. 
6. This unfolded proteins leads to ―Endoplasmic reticulum stress‖ 
which leads to lipid synthesis , depletion of antioxidant and finally 
leading to irreversible liver damage. 
PATHOGENESIS OF STEATOSIS: 
In patients consuming alcohol , the early and reversible effect is 
accumulation of triacylglycerol in the liver, which is seen as fat droplets in the 
microscope has to be stained by special stains like sudan black.  The 
accumulation of triacylglycerol is mainly due to failure of transfer of 
cholesterol from the liver to the periphery which is mediated by an enzyme 
microsomal triglyceride transfer protein , which is kept in inhibitory control by 
alcohol. 
There will be increased damage to cell organelles particularly mitochondria 
leading to loss of protective effect by antioxidants leading to oxidative stress 
and damage to cell membranes. 
Effect of cytokines:  
Cytokines is responsible for most of the clinical and histological 
manifestations of alcohol induced liver injury.  
Tumour necrosis factor alpha induces steatosis and leads to generation 
of reactive oxygen species and free radicals and hepatocyte apoptosis.  
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Interleukin 8 : responsible for activation and recruitment of neutrophils. 
Clinical features  related to cytokines: 
 Fever 
 Anorexia  
 Muscle wasting 
 Catabolic state 
 Neutrophilia 
 Decreased albumin 
 Decreased bile flow 
 Increased collagen 
 Shock 
 Mechanism of Alcohol leading to cancer: 
 Lipid peroxidation 
 DNA mutagenesis 
 Reduced DNA methylation 
Immunological liver damage 
 ―Protein adducts formed from ethanol metabolites andhost proteins can 
act as neoantigens to incite humoralB - cell and cytotoxic T - cell lymphocyte 
responses inALD. Antibodies can be shown against acetaldehydeprotein 
adduct - derived epitopes andhydroxyethyl radical – CYP2E1 adducts . 
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Antibodies can also be seen to native CYP2E1, suggesting that autoimmune 
mechanisms may play a role in alcohol - related liver disease. ― 
―The true importance of immunological mechanisms is not clear as they 
may represent an epiphenomenon whereby immune responses are generatedto 
proteins released from hepatocytes damaged throughother mechanisms.‖ 
Extra hepatic cancers caused by Alcohol: 
 Mouth  
 Pharynx and larynx 
 Oesphagus 
 Colon  
 Breast 
People prone to develop Alcohol depends on the following factors: 
1. Dose of alcohol : to develop cirrhosis the dose should be 160 g /day 
for 8 years , the risk is more in females even at lower dose because 
of poor metabolism of alcohol .Liver injury is unrelated to the type 
of beverage used. It depends more on the pattern of drinking than the 
type of alcohol. 
2. Daily drinking is more dangerous than intermittent drinking. 
3. Diets rich in pork , unsaturated fats and poor carbohydrate diet leads 
to increased risk 
4. Obesity 
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5. Hyperglycemia 
6. Genetic factors 
Females and Alcohol: 
1. Alcohol is poorly soluble in lipids. 
2. Prolonged action due to poor metabolism 
3. Presentation will be at the final stage 
4. More susceptible to liver injury 
5. Relapses are more frequent 
6. More rapid progression 
7. Oestrogen has specific action on gut permeability leading to 
endotoxemia. 
Non - gender - linked genetic factors 
―Patterns of alcohol drinking are, at least partially, inherited; however, 
no specific genetic variants have been reproducibly associated with 
susceptibility in largestudies. Susceptibility to liver disease may also have an 
inherited component. Concordance rates for alcohol -related cirrhosis are three 
times higher in monozygotic than in dizygotic twin pairs . Alcohol – related 
liver damage is a polygenic disorder so multiple polymorphisms are likely to 
contribute. They are likelyto be in genes controlling fat accumulation 
,oxidative stress.  – ―mediated release of proinflammatorycytokines and 
immunological damage . ―IMAGE: Acute alcoholic hepatitis with ballooning 
degeneration, Mallory Denkbodies and satellitosis (neutrophil polymorph 
infiltrate around hepatocytes) 
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“IMAGE: Acute alcoholic hepatitis with ballooning degeneration, Mallory 
Denkbodies and satellitosis (neutrophil polymorph infiltrate around 
hepatocytes) 
 
“Acute alcoholic hepatitis. Hepatocytesare ballooned and contain micro – 
and macrovesicular fat and clumps of purplish – redMallory ’ s alcoholic 
hyaline. (Chromophobeanilineblue, ×100.)” 
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Electron micrograph of liver in a patient with alcoholic liver disease. Note 
the deposition of collagen fibrils in Disse’ s space (arrowed). This could 
interfere with oxygen and metabolite exchange between blood and 
hepatocytes.” 
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HISTOLOGICAL FEATURES 
 FATTY LIVER 
 ALCOHOLIC HEPATITIS 
 CIRRHOSIS 
FATTY LIVER: 
 Initially microvesicular and  later macroveicular fatty change occurs 
predominantly in zone 2 and zone3 .Mitochondrial dysfunction leads to fatty 
acid oxidation inhibition leads to microvesicular fat .  
ALCOHOLIC HEPATITIS: 
 Balooning degeneration, is due to retention of water and failure of the 
microtubular excretion of protein from the hepatocyte cells.  
 Due to apoptosis , acidophilic bodies are seen. 
Mallory denk bodies surrounded by a satellite of polymorphs seen as 
purplish red intra cytoplasmic inclusions which consists of intermediate 
filaments. 
Giant mitochondria can be seen using Masson trichrome stain. Fibrosis 
is maximum around the sinusoids, this pericellular fibrosis called as ―creeping 
collagenosis‖ .  collagen deposition is maximal in the space of Disse leading to 
defect in the transport of substances .cholestasis in the bile canaliculi is 
associated with decreased survival. 
 
 
 
15 
 
CLINICAL FEATURES 
―Patients may present for the first time with the complications of 
cirrhosis or may be asymptomatic and incidentally be identified during checkup 
for unrelated causes or because of abnormal liver tests‖ 
In clinical terms., cirrhosis is classified in to 
 Compensated form and 
 Decompensated form, 
―Decompensation is characterized by cirrhosis complicated by 
one or more following features like  - jaundice, ascites, hepatic 
encephalopathy, bleeding varices. Ascites is usually the first sign of 
decompensation, whereas these features and any complication secondary 
to Portal hypertension is absent in compensated cirrhosis. This distinction 
clinically is very important because of the implication it has in the 
prognostication and treatment.‖ 
  ―A decompensated patient may become compensated when the 
inciting cause or the precipitating cause is removed and thereby the 
prognosis may improve.  
Patients who have developed complications of their liver disease and 
have become decompensated should be considered for liver transplantation.‖ 
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COMPENSATED CIRRHOSIS: 
At this stage the cirrhotic process of the liver is not severe enough to 
alter the function significantly and so the patients may be asymptomatic or 
present with non-localizing manifestations or  picked incidentally due to 
alteration in biochemical parameters or imaging studies Patients may have 
fatigue, anorexia, weight loss, flatulence, dyspepsia, abdominal pain. 
On examination palmar  erythema,  pedal  edema,  spider  naevi,  
may  point  towards  cirrhosis.  
Abdominal examination : epigastric mass which is the enlarged left 
lobe of the liver and splenomegaly.. The most common LFT abnormality in 
this group include mildly elevated transaminases, or GGT. 
Confirmation is by liver imaging or liver biopsy.  
Factors like bacterial infection, trauma, or medications, surgery may 
precipitate decompensation in a compensated cirrhosis.‖ 
DECOMPENSATED CIRRHOSIS: 
These patients present with ascites, jaundice, altered 
sensorium,bIeeding manifestations.‖ 
LIVER PARAMETERS 
―Liver function tests (LFTs) or liver biochemical tests can be used to 
screen for liver disease, direct diagnostic work - up, and assess severity, 
prognosis and response to treatment. Although the term LFT is firmly 
entrenched in the medical literature, this term is frankly erroneous as these 
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investigations provide indirect‖ evidence ―of hepatobiliary disease. LFTs that 
more‖ accurately ―reflect liver function are serum albumin, serum bilirubin and 
prothrombin time, which is standardizedto‖―the international normalized ratio 
(INR). As the‖ prevalence ―of liver disease is only between 2 and 4% in the 
general population (higher for       fatty liver disease‖ andviral ―hepatitis), 
the more investigations are multiplied, the greater chance there is of a 
biochemical abnormality being demonstrated. A few simple tests of established 
value should be used and if an abnormality is found itshould be repeated to 
confirm it is real.‖ 
―LFT abnormalities may be classified into the‖ following ―categories:‖ 
―Hepatocellular (elevations predominantly in aspartate aminotransferase 
(AST) and alanine‖ aminotransferase ―(ALT)); cholestatic (increases‖ 
predominantly ―in alkaline phosphatase (ALP), γ – glutamyltranspeptidase( γ - 
GT) and bilirubin); and infiltrative(increases in ALP, γ - GT and occasionally 
bilirubin).The tests most useful in the diagnostic work - up of‖ jaundice ―are 
the ALP, aminotransferase and bilirubin tests. An isolated rise in serum 
unconjugated bilirubin suggests Gilbert‘s syndrome, haemolysis‖, ineffective 
―erythropoiesis or use of medications such‖ asbunamiodyl (―cholecystographic 
agent) flavaspidic acid, probenicid and rifampicin.‖ 
―The severity of liver cell damage is assessed by serial measurement of 
total bilirubin, albumin and‖ prothrombin ―time after vitamin K. This is 
reflected by theirincorporation into the Childs – Pugh (CP) score and Model for 
Endstage Liver Disease (MELD), which are used to estimate severity and 
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prognosis of liver disease and assess candidacy for liver transplantation‖, 
respectively. ―Rising arterial ammonia levels also reflect severe hepatic 
dysfunction in‖ patients with acute liver failure (ALF) whereas 
hyperammonaemia in decompensated ―cirrhosis does not always correlate with 
hepatic encephalopathy or progression of liver disease.‖ 
―The diagnosis of minimal hepatocellular damage may be suspected by 
noting minimally elevated‖ aminotransferases ―and sometimes serum bilirubin. 
Patients who are heavy drinkers of alcohol with or without liver disease (ALD) 
may have just a raised γ - GT with or without biochemical evidence of liver 
damage. However, this degree of biochemical abnormality also occurs in well - 
compensated cirrhosis, heart failure and fever, reflecting the lack of sensitivity 
and specificity of these investigations for diagnosing and assessing‖ severity 
―of liver disease.‖ 
Bile pigments 
―Bilirubin: ―Total bilirubin is increased in cholestatic and‖ 
hepatocellular ―liver disease more commonly than infiltrative disease. It is 
often associated with a rise in liver enzymes.Bilirubin is predominantly 
conjugated and water soluble. Patients with marked hyperbilirubinaemia 
(bilirubin > 425 μ mol/L) often have severe liver disease coexisiting with renal 
dysfunction or another cause of unconjugated hyperbilirubinaemia, such as 
haemolysis. An isolated rise in bilirubin without enzyme‖elevation ―should 
first―be fractionated to determine if the‖ aetiology ―is familial or due to 
haemolysis.‖ 
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“Serum bilirubin estimations are based on the van den Bergh diazo 
reaction, which involves the‖ spectrophotometric ―detection of azo derivatives 
derived by the‖ reaction ―of plasma with the diazonium ion of sulphanilicacid . 
This reaction separates bilirubin into a water - soluble direct form representing 
conjugated bilirubin and an indirect, lipid - soluble form representing‖ 
unconjugated ―bilirubin. These diazo reactions are subject to error, particularly 
at low total serum bilirubin‖ concentrations.‖More accurate methods for 
estimation include alkaline methanolysis with chloroform extraction, high 
performance gas liquid chromatography (HPGLC), thin layer chromatography 
(TLC) and spectrophotometric determination, but are too elaborate to be 
clinically useful‖ 
“Faecal inspections are an important investigation in jaundice. Clay - 
coloured stools indicate cholestatic‖ jaundice ―but may also occur in 
hepatocellular jaundice. The colour will be normal in haemolytic jaundice. 
Rarely, pale stools occur in very severe bilirubin glucuronyltransferase 
deficiency. Bilirubin cannot be detected in the urine of normal subjects as 
bilirubin is predominantly unconjugated, insoluble in water and bound to 
albumin. In contrast, bilirubin glucuronides, the products of bilirubin‖ 
conjugation,‖ are water soluble. They appear in the urine even when serum 
total bilirubin is normal as the renal‖ threshold ―for glomerular filtration of 
conjugated bilirubin is low. Conjugated bilirubin, however, will bind 
covalently to albumin when jaundice is prolonged and severe, giving rise to a 
complex called δ bilirubin (or‖ bilioprotein) ―.δ bilirubin has a long half - life, 
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cannot be renallycleared and accounts for the absence of bilirubinuria and slow 
resolution of jaundice in patients recovering from severe hepatobiliary 
disease‖. 
“Urobilinogen 
Bacterial β - glucuronidases convert bilirubin in the colon to a series of 
colourless tetrapyrroles collectively called urobilinogen of which 80 – 90% is 
normally excreted in the faeces either unchanged or as oxidized orange‖ 
derivatives ―called urobilins. The remaining 10 – 20% is absorbed and 
undergoes an enteric circulation with re-excretion into bile by the liver while a 
small proportion is excreted in the urine. This complex process depends on 
several factors such as urine flow rate and pH.Spot urinary urobilinogen is a 
poor predictor of hepatic disease with a high proportion of false – negative 
results‖ 
Serum enzyme tests 
These tests usually indicate the type of liver injury, whether 
hepatocellular, cholestatic or infiltrative but cannot differentiate one form of 
hepatitis from another or determine whether cholestasis is intra - or 
extrahepatic.They are valuable in directing specific serological tests, imaging 
or liver biopsy to reach the diagnosis. Only a few tests are necessary and the 
combination of ―normal ALT values should be adjusted for body mass index 
and sex . During pregnancy, ALT, AST and γ - GT levels, as well as bile acid 
and bilirubin concentrations remain within the normal range, whereas an 
elevated alkaline phosphatase is of placental origin during the third trimester.‖ 
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“Aminotransferases 
The aminotransferases (previously called aminotransaminases) catalyse 
transfer of amino groups from either aspartate or alanine to the keto group of α 
–ketoglutaricacid forming oxaloacetic acid (OAA) and pyruvic acid, 
respectively. These enzymes are important in gluconeogenesis as they catalyse 
glucose synthesis fromnon - carbohydrate sources. Enzymatic reduction of 
oxaloacetic acid and pyruvic acid to malate and lactate, respectively, is coupled 
with oxidation of the reducedform of nicotinamide dinucleotide (NADH) to 
nicotinamide dinucleotide (NAD). As only NADH absorbs light at 340 nm, this 
reaction can be followed spectrophotometrically to accurately assay these 
enzymes.‖ 
“Aspartate aminotransferase (AST; serum glutamic oxaloacetic 
transaminase or SGOT) is an isoenzyme located in the cytoplasm and 
mitochondria of manytissues. Although normal AST serum activity is‖ 
―cytosolic in origin, 80% of AST activity within the liver is mitochondrial and 
predominates in periportal hepatocytes.‖ 
―In decreasing order of concentration AST is present in large quantities 
in liver, heart, skeletal muscle, kidneys, brain, pancreas, lungs, leucocytes and 
erythrocytes.Macro - AST is a rare condition characterized by isolated AST 
elevation due to binding of AST with an immunoglobulin which is not cleared 
by the blood or kidneys] . It is a benign condition and is not reflective of liver 
disease. Markedly low AST levels have been reported in patients on chronic 
haemodialysis, possibly due to dialysis or pyridoxine deficiency.‖ 
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“Alanine aminotransferase (ALT; serum glutamic pyruvic transaminase 
or SGPT) is a cytosolic enzyme also present in liver. Although the absolute 
amount is less than AST, a greater proportion is present in liver compared with 
kidney, heart and skeletal muscles. A serum increase is therefore more specific 
for liver damage than AST‖. 
―Transferase determinations with viral serologies are useful in the early 
diagnosis of viral hepatitis, but there is no correlation between transferase level 
with eitherthe degree of hepatocyte necrosis or prognosis.Measurements should 
be performed promptly as these enzymes ―have short half - lives (AST 12 – 22 
h; ALT 37 – 47h) . Patients may develop fatal acute hepatic necrosis despite 
falling transaminase values‖. 
―Routine screening may show unexpectedly raised aminotransferase 
levels. These are often due to non - alcoholic fatty liver disease (NAFLD), 
alcohol abuse, viral hepatitis and haemochromatosis. Less common causes 
include autoimmune hepatitis, α1-antitrypsin deficiency, Wilson‘s disease, 
drug – induced liver disease and non - hepatic disorders such as Addison ‘ s 
disease, anorexia nervosa, celiac disease and hyperthyroidism. Important 
causes of markedly elevated transaminases are viral hepatitis (including herpes 
simplex hepatitis), paracetamol(acetaminophen) or other drug - induced 
hepatotoxicity, ischaemic hepatitis and severe autoimmune hepatitis .Calculous 
biliary obstruction with cholangitis is animportant but frequently under 
appreciated cause of AST elevation greater than 10 times the upper limit of 
normal, which may improve with antibiotics over 48 –72 h despite unresolved 
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obstruction. Very high levels are unusual in ALD and suggest a coexisting 
disorder such as paracetamol toxicity or acute viral hepatitis. A ratio of AST to 
ALT greater than two may be useful in diagnosing ALD. This occurs because 
damage is primarily mitochondrial (thus more AST is released systemically) 
and ALT synthesis is more sensitive than AST to pyridoxal 5 - phosphate 
deficiency, leading to lower serum ALT levels .  
“Alkaline phosphatase” 
―The alkaline phosphatases (ALP) are a group of enzymes that catalyse 
hydrolysis of phosphate esters at neutral pH. Magnesium and zinc are 
important co - factors. ALP in the liver is cytosolic, associated with sinusoidal 
and canalicular membranes and rises in cholestasis and to a lesser extent when 
liver cells are damaged.‖ 
―ALP is present, in decreasing order of quantity, in placenta, ileal 
mucosa, kidney, bone and liver but more than 80% of serum ALP is from the 
liver or bone. ALP half - life is 3 days. Bone, liver and kidney ALP are coded 
by the same gene and share a common protein structure but differ in their 
carbohydrate content. Mechanisms of the increase are believed to be related to 
increased hepatobiliary synthesis from enhanced translation of messenger 
ribonucleic acid of ALP and serum secretion through canalicular leakage into 
the sinusoid rather than failure to excrete ALP. Due to de novo ALP synthesis 
in acute biliary obstruction, serum levels are initially normal in contrast to 
marked transferase elevations. Serum hepatic ALP may be distinguished from 
bone ALP by isoenzyme fractionation but this is not routinely carried out as a 
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concomitant rise in γ - GT confirms ahepatobiliarysource.An isolated rise in 
ALP may also be‖―of intestinal origin, as observed in patients with blood 
groups O and B who secrete intestinal ALP postprandially. As these enzymes 
may‖ ―remain elevated for up to 12 h, levels mustbe determined under fasting 
conditions . Up to 52% of patients with mild isolated ALP elevations (less than 
two fold elevation) will have enzyme normalizationwithin 1 – 3 months 
although in hospitalized patients, sepsis in the absence of jaundice may account 
for up to 32% of cases. Raised ALP levels are sometimes observed with 
primary or secondary hepatic tumours, even without jaundice or involvement 
of bone. Increased values without jaundice are also found with other space -
occupying lesions or infiltrative disease such as amyloid, abscess, lymphoma 
or granulomas. Non - specific mild elevations are seen in a variety of 
conditions including Hodgkin ‘ s disease, heart failure, hyperthyroidismand up 
to 15% of patients with renal cell carcinoma in the absence of involvement of 
the hepatobiliary system or bone (Stauffer ‘ s syndrome). Low ALP levelsare 
associated with hypothyroidism, Wilson‘s disease with haemolysis, congenital 
hypophosphatasia, pernicious anaemia, zinc deficiency, severe hepatic 
insufficiency and in children recovering from severe enteritis.‖ 
“Gamma” glutamyltranspeptidase or transferase 
―Gamma glutamyltranspeptidase (γ - GT) is a membrane-bound enzyme 
that catalyses transfer of γ glutamyl groups of peptides such as‖―glutathione to 
other amino acids. Levels are increased in cholestasis and hepatocellular 
disease and occur in the same spectrum of hepatobiliary‖ ―diseases as elevated 
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ALP. γ - GT is ubiquitous but in decreasing order of abundance is present in 
proximal renal tubule, liver, pancreas (acinar cells and ductules) and intestine. 
Serum γ - GT activity arises primarily from the liver and, within the 
hepatobiliary system, is present in highest concentration in the epithelium 
lining of fine biliary ducts. The main role of this test is to confirm a raised ALP 
is of hepatobiliary origin‖. 
―An isolated rise in γ - GT is seen in patients with alcohol abuse, even 
without liver disease, due to microsomal enzyme induction and impaired 
clearance (half - life of 7 – 10 days increases to 28 days). Screening for γ - GT 
may have led to more alcohol abusers being identified although levels do not 
rise in one - third of individuals. There also is no correlation between alcohol 
consumption and elevated serum γGT levels with hepatic γ – GT in patients 
with biopsy - proven alcoholic liver disease. An increased level can lead to 
over - investigation inan individual who has never taken alcohol or a 
socialdrinker who has never abused alcohol.‖ 
HEMATOGICAL MARKERS OF ALCOHOLISM 
State Markers 
―Chronic ingestion of large quantities of alcohol alters many 
physiological andbiological processes and compounds, including several blood-
related (i.e., hematological) variables. Because blood samples are―relatively 
easy to obtain, structural and functional changes in circulating blood cells and 
plasma proteins potentially can form the basis of laboratory tests for screening, 
diagnosing, and monitoring alcoholism. Two hematological state markers 
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commonly used for these purposes are the presence of carbohydrate-deficient 
transferring (CDT) in the blood and an increase in the size of red blood cells 
(RBC‘s), as measured by the mean corpuscular volume (MCV).‖ 
Carbohydrate-Deficient Transferrin. 
―CDT is one of the newest—and perhaps the most promising—of 
thehematological state markers. Transferrin is an iron-containing protein in the 
plasma that transports iron, which is stored at various sites in the body, to the 
developing RBC‘s in the bone marrow for incorporation into hemoglobin. 
Transferrin molecules in the blood usually contain several carbohydrate 
components. In chronic heavy drinkers, however, the number of carbohydrate 
components in each transferring molecule is reduced, resulting in CDT. The 
mechanism underlying this alteration still is unclear.‖ 
―Because elevated CDT levels in the blood appear to be a specific 
consequence of excessive alcohol consumption, a recent study investigated the 
utility of repeatedly monitoring serum CDT to detect relapse among recovering 
alcoholics. The study found that in most of the‖―subjects who relapsed, the 
elevation of CDT levels preceded self-reported alcohol consumption by at least 
28 days. These findings suggest that repeated testing of alcoholic patients for 
CDT permits early relapse detection and thus may lead to early intervention. 
Early intervention, in turn, may decrease the need to rehospitalize patients for 
alcohol withdrawal and prevent some of the complications associated with 
sustained excessive drinking. “ 
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SYMPTOMS: 
―Presentation in these patients may be with features of jaundice, 
pedal edema, abdominal distension, pruritis. 
Upper GI bleed most commonly result in malena, hematemesis. 
Altered sensorium ranging from sleep disturbances to florid confusion and 
coma because of hepatic encephalopathy. 
 ‗In women, menstrual irregularities are common due to 
anovulation. Men, may manifest hypogonadism in the form of impotence, 
loss of sexual drive, testicular atrophy and infertility.‖ 
 ―Portal hypertension is an important  complicating feature of 
decompensated cirrhosis and is responsible for the development of ascites and 
bleeding from esophagogastric varices  which  makes cirrhosis 
decompensated‖ . 
GENERAL EXAMINATION: 
Decreasing blood pressure - with progression of cirrhosis, mean 
arterial pressure often decreases.  
 Hypertensive patients may become normotensive. 
 Patients presented with mild fever  (37.5  -38*C). 
 This is probably because of bacteremia due to gram negative 
organisms. Ongoing hepatocyte necrosis and development of 
hepatocellular carcinoma may also contribute. 
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Jaundice happens once the functional impairment due to hepatocyte 
destruction has exceeded the process of regeneration. The deeper the 
jaundice, more severe is hepatic decompensation. 
“Skin findings: 
Bronze pigmentation of the skin occurs in hemochromatosis. 
Presence of "vascular spiders‖ /arterial spiders/spider naevi / spider  
telengiectasia spider angioma. They are seen in distribution of venous 
drainage areas of superior vena cava. As liver function worsens, new 
spiders may appear. They are more frequently associated with alcoholic 
cirrhosis.  
They occur normally in pregnancy and in some normal 
individuals. 
Hepatopulmonary‖ syndrome is characterized by multiple spiders 
and clubbing. 
―Palmar erythema‖: palms are warm and red in colour especially 
over the thenar eminence, hypothenar eminence and the pulp of the fingers.  
Mechanism of arterial spiders and palmar erythema may be due to 
estrogen excess. The estrogens are inactivated in the liver. 
Serum estradiol level is normal and serum free testosterone is 
reduced.   
  High estradiol /Free testosterone ratio may he attributed to these 
findings. 
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―Leukonychia‖  may be related to hypoalbuminemia. ―Clubbing‖ can 
occur pan digitally especially with development of hepato pulmonary 
syndrome or in cystic fibrosis.‖Hypertrophic osteoarthropathy‖ has also 
been observed. 
―Dupuytrens contracture‖ may be present.This is characterized by 
thickened palmar fascia resulting from unorganized proliferation of the 
fibroblasts. 
Head and neck findings- 
Parotid enlargement, alopecia, fetor hepaticus,  
KF ring in the eyes due to Wilson's disease may be present. 
―Fetor hepaticus‖ refers to the breath of the cirrhosis patients that 
has a sweet pungent nature. This is because of presence of mercaptans. 
Chest findings : 
Gynecomastia in males may be seen along with other features of 
feminization like change in the male pattern of pubic hair, loss of 
axillary hair and chest hair. Gynaecomastia  is because the androstenedione 
that is synthesized by the adrenals gets aromatized in to estrone and finally in 
to estradiol in the adipose tissue. 
Abdominal findings- 
Abdominal examination  reveal the presence of ascites, hepatomegaly, 
splenomegaly, and dilated abdominal wall veins. 
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―Ascites‖ — Ascites refers to excessive collection of peritoneal fluid.  
Hepatomegaly‖ -The cirrhotic liver may be enlarged, shrunken or 
normal sized. On palpation, consistency is firm and nodular.  
Features such as shape, consistency are to be better appreciated on 
palpation as the estimation of liver size correlates less accurately with 
imaging studies. Presence of a palpable liver in cirrhosis : alcoholic 
liver disease, primary biliary cirrhosis, hemochromatosis, 
transformation into hepatocellular carcinoma, Budd Chiari 
syndrome. 
―Splenomegaly‖- Splenomegaly in cirrhosis is due to congestion 
resulting from portal hypertension. correlation between splenic size and 
portal pressure is poor- implicating that there  may be other factors 
contributing. 
―Caput medusae‖ - With the development of portal hypertension,the 
portal venous blood gets carried through the periumbilical veins in to the 
umbilical vein which becomes patent in cirrhosis ,from there the blood 
drains in to the upper and lower abdominal veins that end up in the 
systemic circulation . 
These veins become engorged and prominent. 
Thus the portal blood gets shunted to systemic circulation. This 
appearance resembles the head (Caput) of the mythical Gorgon Medusa thus 
termed caput medusae. 
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Dilated abdominal veins developing in SVC obstruction and IVC 
obstruction should be differentiated from  dilated veins due to cirrhosis. 
  In IVC obstruction the flow is below upwards whereas in cirrhosis 
the flow of the blood is away from the cause of obstruction direction or 
flow is to be assessed.  
IVC obstruction the flow is below upwards. However since these 
veins in both conditions may lack valves, the flow may be bidirectional 
and the test may be misleading. Moreover the dilated veins due to 
obstruction are more commonly seen in the back and loin. 
―Peptic ulcers‖ occur in 11% of cirrhosis patients. 
  Duodenal ulcers are more frequentiy encountered than gastric 
ulcers. Colonization by helicobacter pylori is higher in cirrhosis when 
compared to normal population. Abdominal hernias are more common in 
patients with ascites. They should be repaired only if severe enough to 
cause mortality in alcoholics.Associated chronic pancreatitis  can be 
present which may relapse,so this should be considered a differential 
diagnosis in alcoholic cirrhosis patients presenting with abdominal pain. 
Neurological findings - The presence of Asterixis or liver flap 
indicate the presence of hepatic encephalopathy. 
Genitourinary findings-   Testicular atrophy in males. 
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Endocrine changes- Hyperglycemia occurs in about 80% of cirrhotic 
patients in the form of glucose intolerance. Only around 10-20% are truly 
diabetic. 
Hematologic abnormalities- Thrornbocytopenia, anemia and 
lencopenia can occur. The earliest abnormality to occur is 
thrombocytopenia and it is a marker for the development of portal 
hypertension.  
―Pancytopenia‖ can even be the presenting feature in asymptomatic 
compensated cirrhosis. This is due to sequestration of the cells in the 
enlarged spleen. 
 Platelet count usually does not fall below .50,000.This does not per 
se cause bleeding but bleeding can get aggravated in the presence of 
coagulopathy. 
―Anemia‖ in cirrhosis is mainly because of upper G1 bleed. 
Anemia can also be present as a result of direct suppression of bone 
marrow by alcohol,splenic sequestration and hemolysis, folate deficiency. 
Other abnormalities - In cirrhosis, the globulin levels are high. This 
is because of shunting of bacterial antigens in the portal venous blood 
which are normally filtered by the liver in to systemic circulation leading 
which induces production of immunoglobulins.  
Marked elevations of IgG may point towards the presence of 
autoimmune hepatitis. 
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Imaging studies: 
• Ultrasonography - Ultrasonography is a non-invasive routinely 
used investigation to diagnose cirrhosis; the size of the liver, the 
nodularity, the portal vein diameter, presence of ascites and 
splenomegaly can be  assessed.  
• Doppler studies to check the direction of blood flow in the  
portal vein aids in the diagnosis of portal hypertension. Presence 
HCC  and portal vein thrombosis can also be made out. 
• CT is not the first choice in the diagnosis of cirrhosis. It may be 
useful when investigating  liver  malignancy  or  secondaries  or  
pancreatic pathology. 
• MRI helpfull in hermochromatosis to reveal iron overload.  
• MRA can determine portal vein flow and dynamics. 
• Elastography to assess the stiffness of the liver tissue is also available.‖ 
―Liver biopsy: 
The gold standard investigation for diagnosing cirrhosis is liver 
biopsy Nowadays liver biopsy is rarely required to diagnose cirrhosis.Only  
certain  situations  may  require  performing  liver  biopsy  such  as  
for dermonstrating the underlying metabolic cause of cirrhosis such as 
NASH, Wilson disease, hemochromatosis, and alpha 1 antitrypsin 
deficiency.‖ 
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Complication of Cirrhosis: 
 
“VARICES : 
Varices are important cause for upper gastrointestinal bleeding. 
Varices reflects the presence of portal hypertension. Portal hypertension is 
defined as elevated hepatic venous portal gradient more than 5 mmHg. 
Anatomy and physiology of Portal venous system : 
The portal vein is formed by the confluence of the superior 
mesenteric and splenic veins. 
Spleenic vein drains blood from the spleen, fundus of stomach and 
part of the pancreas. Inferior mesenteric vein drains blood from the large 
intestine - transverse colon,descending colon and rectum – superior two 
thirds usually joins the spleenic vein Superior mesenteric veins drain blood 
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from small intestine, large intestine, stomach , pancreas and appendix.  
 
 
Portal hypertension leads to two major complications – variceal 
hemorrhage and ascites. 
Pathophysiology of varices formation : 
Anatomically collaterals usually exists between the portal venous 
system and the systemic venous system at certain anatomic locations. Blood 
flows from the systemic circulation into the portal system. 
Two pathogenesis contributing to portal hypertension are 
 Increased resistance to portal venous flow due to extrahepatic 
obstruction or intrahepatic resistance due to cirrhosis and 
regenerative nodules. 
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 Increased splanchic blood flow due to vasodilation of splanchic 
circulation. 
 
Fig. Collaterals formation at esophagus in portal hypertension 
When portal hypertension develops, the resistance in the portal vessels 
pressure raises more than that of the systemic system, and causes reversal of 
flow . This is transmitted to the portosystemic junctions and the collaterals 
become dilated and distended 
Angiogenesis and new blood vessel formation also occur with an effort 
to increase collataeral bed to decompress the portal hypertension but when the 
collateral is unable to withstand the pressure, dilation of vessels occur. further 
compromise leads to complication of rupture and bleeding. 
Varices should be kept in mind while treating all patients with clinical 
picture of liver cell failure. Once diagnosis of cirrhosis is made, the patient 
should be subjected to endoscopy to rule out varices and appropriate 
management should be done. When absent, periodic review and yearly 
endoscopy should be done 
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Causes of portal hypertension 
1.Prehepatic causes 
Portal vein obstruction 
 Idiopathic 
 Cirrhosis 
 Infection 
 Pancreatitis 
 Abdominal trauma. 
 Coagulation disorders 
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- polycythemia vera, 
- essential thrombocytosis, 
- deficiencies in protein C, 
- protein S deficiency, 
- antithrombin 3 deficiency, 
- factor V leiden  
- Spleenic vein thrombosis 
- Massive spleenomegaly – Banti‘s syndrome 
2. Hepatic causes : 
Presinusoidal 
- Schistosomiasis 
- Congenital hepatic fibrosis Sinusoidal 
- Cirrhosis of any etiology 
- Alcoholic hepatitis 
- Postsinusoidal 
- Hepatic sinusoidal obstruction 
3. Post hepatic causes 
- Budd-Chiari syndrome 
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- Inferior vena caval webs 
- Cardiac causes 
- Restrictive cardiomyopathy 
- Constrictive pericarditis 
- Severe congestive heart failure 
 
Fig.Causes of portal hypertension 
Esophageal varices: 
Gastroesophageal collateral bed is the common site of variceal 
formation and bleeding. When the HVPG exceeds 10 mm Hg, esophageal 
varices develops. In esophagus, the varices along the lower 2 to 3 cm 
submucosa lies very superficial, have fragile thin wall and so why bleeding 
usually occurs at this site. These vessels do not communicate with the 
 
 
40 
 
periesophageal veins and therefore cannot easily be decompressed(8)*. 
 
Fig: Esophagus - subcutaneous venous plexus 
 
Esophageal varices may be small – less than 5mm or large –greater than 
5 mm.Small varices progress with time into large varices. The predictors of 
first bleeding include the size of varices, severity of cirrhosis (Child B or C), 
variceal pressure (>12 mm Hg), and the endoscopic presence of red wale 
marks (5). 
“Gastric varices : 
Gastric varices occur less common than esophageal varices around 5 – 
30% (5) of portal hypertension. Bleeding occurs in about one-fourth of them. 
Gastric varices can occur in isolation or as extension of esophageal varices. 
Gastic varices are classified according to the site and association with 
esophageal varices. (Sarrin et al.) 
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Gastroesophageal varices  [2] 
 Type 1 varices - extend along the lesser curvature. 
 Type 2 varices - extend along the fundus. They are longer and 
more tortuous than GOV1 
Isolated Gastric varices [ 2 ] : 
 Type 1 - fundus and tend to be tortuous and complex 
 Type 2 - body, antrum, or around the pylorus. 
Isolated gastric varices at fundus may occur due to spleenic vein 
thrombosis and should be ruled out. 
Ectopic varices: 
Varices may occur anywhere in the gastrointestinal tract.when 
present in GI tract other than esophagus and stomach, they are termed as 
ectopic varices. They are difficult to identify and continue be a concealed 
source of bleeding.once identified the appropriate treatment modalities are 
not well established. Management Endoscopy has evolved as the principal 
diagnostic as well as therapeutic tool in management of upper 
gastrointestinal bleed. Endoscopy era has made to review the etiology of 
upper GI bleed as the most common cause varies with region. It helps in 
identifying individuals and categorising them accordingly to be managed by 
primary prophylaxis in newly diagnosed cirrhotic or need for endoscopic 
intervention or surgery. 
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HEPATO PULMONARY SYNDROME: 
Diagnostic criteria for Hepato Pulmonary Syndrome consist of the 
following: 
1. The presence of liver disease and / or portal hypertension 
2. An elevated room air alveolar-arterial oxygen gradient [P(A-a) O2 
gradient] > 15mmHg or > 20mmHg when age > 65years. 
3. Evidence of intrapulmonary vascular dilatations in the basal parts of the 
lungs 
4. Absence of other significant cardio pulmonary disease 
 A relationship between the liver and the lung was first noted by 
Fluckiger based on his observation of a women with cirrhosis , cyanosis and 
clubbed digits.Kennedy and Knudson(1997) described the word 
―hepatopulmonary syndrome‖ which is characterized by hypoxemia and 
intrapulmonary vascular dilatations(ref 6).Hepatopulmonary syndrome is a 
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complication of liver disease,especially portal hypertension.It is most 
commonly associated with chronic liver disease, although it has also been 
described in the context of acute liver disease. The clinical features of Hepato 
Pulmonary Syndrome are due to both hepatic and pulmonary dysfunction.More 
than 80% of patients present with symptoms of liver disease, the remainder 
experience dyspnea as their initial symptom. Hypoxemia,platypnea and 
orthodeoxia are characteristic findings.Impaired oxygenation is confirmed 
when Arterial blood gas analysis demonstrates an elevated room air alveolar-
arterial oxygen gradient [P(A-a) O2 gradient] > 15mmHg or an arterial oxygen 
gradient (pao2) of < 80mmHg while breathing room air(ref 7).Intrapulmonary 
vascular dilatations may be identified by contrast enhanced echocardiography, 
macroaggregated albumin scanning, and pulmonary arteriography. contrast 
enhanced echocardiography is generally preferred because it is more sensitive 
than macroaggregated albumin and less invasive than pulmonary 
arteriography(ref 8).  contrast echocardiography is performed by injecting a 
contrast material usually agitated saline and then performing echocardiography. 
under normal circumstances, the contrast opacifies only the right heart 
chambers because it is filtered by the pulmonary capillary bed. However 
contrast may opacify the left heart chambers if a right to left intracardiac or 
intrapulmonary shunting is present. With an intracardiac shunt, contrast 
appears in the left heart within three heart beats after injection. In contrast, with 
an intrapulmonary shunt, contrast generally appears in the left heart three to six 
heart beats after its appearance in the right heart. In patients with liver disease, 
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detection of an intrapulmonary right to left shunting is considered indicative of 
Intra Pulmonary Vascular Dialatations. pulmonary arteriography is generally 
reserved for excluding alternative causes of hypoxemia, pulmonary 
hypertension and large direct arteriovenous communications. Three 
angiographic patterns were described.Type 1 minimal pattern was characterised 
by normal to finely diffuse,spidery abnormalities.It was associated with severe 
hypoxemia,orthodeoxia and a good response to 100% inspired oxygen. The 
type 1 minimal pattern may evolve into a type 1 advanced pattern, which was 
characterized by a diffuse spongy or blotchy angiographic appearance. It is less 
responsive to 100% inspired oxygen. Type 2 discrete pattern was characterized 
by localized arteriovenous communications and is associated with poor 
response to supplemental oxygen.(ref 8). At present, the most effective and 
only radical treatment is liver transplantation. Cirrhotic patients who are on the 
waiting list for an liver transplantation have a shorter survival period if they 
develop Hepato Pulmonary Syndrome. Therefore, it is suggested that all 
cirrhotic cases should be followed closely for Hepato Pulmonary Syndrome 
and should have priority in the waiting list.‖  
―Hepato Pulmonary Syndrome is an important complication of 
cirrhosis,causing dyspnea and cyanosis in cirrhotic cases. There is no relation 
between the development of Hepato Pulmonary Syndrome and the severity of 
cirrhosis.‖ 
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LIVER AND GLUCOSE 
“ROLE OF LIVER IN GLUCOSE METABOLISM 
1. Liver is the organ of glucose production and glucose consumption 
2. It is exposed to insulin concentration in the portal circulation which is 3 
– 10 times more the systemic circulation. 
3. Sole site of glycol regulatory action of glucose 
4. Absorbed hexose‘s reach liver before reaching muscle and adipose 
tissues. 
Liver has storage of glucose and glycogen about 70gm aat a time. 75% 
of hepatic glucose output comes from gluconeogenesis. 
Contribution of liver in glucose homeostasis depends on the following 
factors: 
1. Sensitivity of hepatocytes to small increments in insulin levels 
2. Ratio of insulin to glucagon 
3. Responsiveness of glycogenolysis and gluconeogenesis to hormonal 
modulation. 
HEPATOGENOUS DIABETES 
INTRODUCTION 
Hepatogenous diabetes is a common complication of diabetes. The liver 
plays a very important role in glucose metabolism. Thus, in the presence of 
chronic liver disease, the homeostasis of glucose metabolism is impaired and 
results in glucose intolerance and diabetes mellitus (DM) type 2.About 50% - 
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80% of cirrhotic patients have IGT and 30% - 40% develop DM. Sometimes, 
DM in cirrhosis may be subclinical, since fasting serum glucose may be 
normal. In these cases, it is necessary to perform an oral glucose tolerance test 
(OGTT) to detect an impairment of glucose metabolism . Also DM increases 
the risk of complications of cirrhosis and reduces survival rate. Moreover these 
patients having increased peripheral resistance and altered adipocyte 
sensitivity. To compensate for insulin resistance (IR) pancreatic insulin 
secretion increased. 
MECHANISM: 
DM can increase fibrosis, incidence of hepatocellular carcinoma, and 
resistance to antiviral therapy in patients with cirrohosis. DM may be involved 
in the progression of liver fibrosis and inflammation through diverse 
mechanisms: it is likely that adipokine production (such as leptin and Tumor 
necrosis factor-alpha, which activate inflammatory pathways exacerbating liver 
injury) is increased by insulin resistance. Leptin and oxidative stress associated 
with liver inflammation may activate transforming growth factor beta 1(TGF-
β1), which is one of the most potent profibrogenic cytokines produced in the 
liver. TGF-β1 activates hepatic stellate cells which are the major source of 
collagen and extracellular matrix proteins. 
CLINICAL IMPLICATIONS: 
DM increases the incidence of severe infections by inducing 
immunosuppression. Cirrhotic patients with DM have a higher prevalence of 
infections compared to non-diabetic ones.Spontaneous bacterial peritonitis was 
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more frequent in patients with cryptogenic cirrhosis(which is associated with 
DM) compared to those with cirrhosis of other causes. These infected patients 
had higher mortality due to sepsis, liver failure, and hepatorenal syndrome. In 
addition, DM may increase the risk of variceal bleeding, as postprandial 
hyperglycemia that occurs in diabetic patients produces splanchnic 
vasodilatation and increases the flow and pressure of the porto systemic venous 
system. Also, esophageal variceal bleeding increases the risk of infection and 
death by inducing bacterial intestinal translocation. DM has been also 
associated with increased risk of hepatic encephalopathy.    
Hepatogenous diabetes is less associated with retinopathy, 
cardiovascular and renal complications and more frequently associated with 
hypoglycemic episodes as a result of impaired liver function. Liver disease 
abnormalities (low intravascular coagulability, low cholesterol, lower 
prevalence of hypertension) as well as shorter duration of DM may explain 
relatively lower rate of diabetic complication in chronic liver disease‖. 
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Hepatitis B: 
 Around 2 billion people in the world are infected with Hepatits B 
virus.out of them 400 million are chronically infected. Most of them are 
asymptomatic carriers and most of them will progress to chronic hepatitis, 
decompensated liver disease and hepatocellular carcinoma. HBV may be 
attributed to one of the main cause for hepatocellular carcinoma and it is the 
second leading carcinogen while tobacco remains the first worldwide. 
According to the prevalence of chronic Hepatitis B ,it can be classified as : 
 Highly prevalent : more than 8 percent 
 Intermediate prevalent : 2 to 5 percent  
 Low prevalent : less than 2 percent 
Countries with high prevalence are : south East Asian countries and 
China Intermediate prevalance : central Asia and Mediterranean countries 
Low prevalance : USA ,Australia and New Zealand 
Overall the prevalance of the disease is reduced due to increased 
awareness and hepatitis B Vaccination and also due to health education and 
better sanitation. 
“CHRONIC HEPATITIS B : 
 Chronic hepatitis B represents a series of liver diseases due to etiology 
and severity in which hepatic necrosis and inflammation persists for more than 
6 months . 
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 Post viral chronic Hepatitis  and Alcoholic liver disease are the major 
causes of decompensated Chronic Liver Disease. 
Other causes for Chronic Liver Disease: 
 Auto immune hepatitis 
 Wilson disease 
 Non alcoholic fatty liver disease 
 Hemochromatosis 
 Cryptogenic cirrhosis 
 Drug induced and Metabolic disorders. 
According to the immune reaction , it is classified into,  
 Immune tolerant stage 
 Immune clearance stage 
 Quiescent stage 
Immune tolerant stage:  
 Neonatal period is considered as immune tolerant phase where in there 
is very little immune reaction and less damage to the liver and mild elevation in 
the transaminase level but there is very high viral load and HBeAg positivity. 
Immune clearance phase : 
 Age 10 to 20 is considered as highly reactive immune phase that 
produces high clearance of viruses and extensive liver damage. Enzyme 
elevation in this phase is very high and HBV load is very low. 
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Quiescent stage :  
 In older age immune response is very low and it is called quiescent stage 
wherein both HBV DNA and enzyme elevation is very low. 
They rarely progress to chronic hepatitis. Presence of HbsAg greater 
than 6 months is considered as chronic hepatitis B. 
Estimated 5 year survival rate  of progression to Chronic Hepatitis B: 
Chronic hepatitis leading onto cirrhosis : 10 to 20 percent 
Compensated cirrhosis to Decompensated Cirrhosis : 20 to 30 percent 
Compensated cirrhosis turning into hepatocellular carcinoma : 5 to 15 
percent 
Survival rate :  
 For compensated cirrhosis – 85 percent at 5 years 
 Decompensated cirrhosis – 55 to 70 percent at first year and 15 to 35 
percent at 5 years. 
Factors  modifying the course of Hepatitis B Infection: 
Duration and amount of viral replication : 
Presence of viral replication can be assessed with markers like HBeAg 
positivity and HBV DNA levels. The more the duration and extent of viral 
replication decides the progression of patient to cirrhosis and hepatocellular 
carcinoma. HBV DNA levels are used as a primary marker now and it has been 
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incorporated into the guidelines for treatment of CHB patients. Chronic 
Hepatitis B should be treated to avoid the progression of liver disease. 
2.Alcohol use : 
Heavy alcohol consumption along with HBV leads to faster progression 
of liver disease as does the risk of HCC and development of cirrhosis. 
3.Hepatitis C : 
When co-infection of HCV and HBV occurs , manifestations of HCV 
predominates, with very low level of replication but the rate of progression to 
cirrhosis and carcinoma much faster. The rate of fulminant failure is increased 
in both HBV and HCV infection on CHB patients. 
Indication of Anti viral therapy in CHB patients: 
There are many guidelines for treatment of which the newly published 
one is German Guidelines: 
1. 1.HBV DNA level > 2000 IU/ml or >10,000 copies/ml  
2. Any elevation of ALT and histological grading and staging. 
3. Patient with cirrhosis or advanced cirrhosis and detectable viremia 
4. Reactivation of HBV replication due to immunosuppression, should be 
avoided by preventive therapy. 
5. alcohol and drug consumption are not a contra indication for treatment 
6. Antiviral in pregnancy: Lamivudine and tenofovir continued during 
pregnancy. 
 
 
52 
 
Goals of therapy for HBV: 
Aim of treatment is to prevent the progression of liver disease to 
cirrhosis or hepatocellular carcinoma 
Clinical parameters used in assessment are : 
1. Loss of HBeAg in a HBeAg positive patient with the development of 
anti HBE . This is called  e antigen seroconversion.. 
2. Loss of HBsAg and development of anti HBs 
3. Normalisation of serum transaminases 
4. Very low or undetectable viral DNA level 
5. Histological improvement in liver biopsy 
Drugs used for chronic hepatitis B : 
1. 1.Lamivudine 
2. 2.Adefovir 
3. 3.telbivudine  
4. 4.tenofovir 
5. Pegylated interferon 2 alpha‖ 
Prolactin  
Causes of hyperprolactinemia: 
1.physiological hypersecretion: 
 Pregnancy 
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 Lactation 
 Chest wall stimulation 
 Sleep and stress 
2.hypothalamic pituitary stalk damage: 
 Tumours  
 Craniopharyngioma 
 Suprasellar pituitary mass 
 Meningioma 
 Dysgerminoma 
 Metastases  
 Empty sella 
 Lymphocytic hypophysitis 
 Adenoma with stalk 
 Compression  
 Granuloma  
 Rakhthes cyst 
 Irradiation and trauma  
 3.pituitary hypersecretion:  
 Prolactinoma and acromegaly 
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4. Systemic disorders: 
 Chronic renal failure‘ 
 Hypothyroidism 
 Cirrhosis 
 Epileptic seizures 
 Pseudocyesis 
Drug induced hyper secretion: 
Dopamine receptor blockers: 
 Atypical antipsycotics 
 Phenothiazenes 
 Haloperidol 
 Thioxanthine 
 Metoclopramide 
 Dopamine synthesis inhibitors: alpha methyldopa 
 Catecholamine depletors :reserpine  
 Opiates 
 H2 antagonists 
 Calcium channel blockers 
 Fluoxetine 
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 Estrogens  
 Thyrotropin releasing hormone 
―Hyper prolactinemia is defined as prolactin level more than 200 ug /L 
Most common cause : PRL secreting pituitary adenoma Chronic renal failure 
elevates prolactin level by decreasing the peripheral clearance Primary 
hypothyroidism is associated with mild hyperprolactinemia due to 
compensatory increase in thyrotropin releasing hormone  
 Lesion of the hypothalamic pituitary region:  
Disrupts the dopamine synthesis 
 Portal vessel delivery 
 Lactotrope response  
Prolactin level in the range of 100 to 300 ug/L 
 Hypothalamic disorders 
 Infiltrative disorders 
 Radiation induced damage 
 Presenting features: 
Amenorrhea ;galactorrhea and infertility are the hallmark of 
hyperprolactinemia. Vertebral bone mineral density can be reduced. 
 Decreased libido 
 Weight gain 
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 Mild hirsuitsm 
In men : loss of libido and infertility and visual loss are the presenting 
complaints. Osteopenia ,decreased beard growth and reduced muscle mass 
secondary to decreased testosterone. 
Galactorrhea is sometimes associated with acromegaly. 
Lab investigations: 
 Basal fasting morning PRL level < 20 ug/L 
 Hypothyroidism will be excluded by measuring TSH and T4 level. 
 Prolactinoma : Tumors arise from the lactrotrophe cells, accounts for 50 
percent of the cases 
 Male to female ratio= 20 :1 
 Tumour size correlates with the PRL level 
 Micoadenomas < 1cm in diameter 
 Macro adenomas more than 1cm invade the parasellar regions and 
impinge on the nearby structures. 
 Value more than 250 ug/L correlates with macroadenoma. 
 MRI should be performed in all patients with hyperprolactinemia.it is 
important to remember that hyperprolactinemia caused by non 
lactotrope cells is also corrected by treatment with dopamine 
agonists.despite failure to shrink the underlying mass. 
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 Prolactin suppression by dopamine agonists does not necessarily 
indicate that the underlying mass is a prolactinoma. 
 Treatment goal for prolactinoma: 
 Control of hyperprolactinemia 
 Reduction of tumour size 
 Restoration of menses and fertility 
 Resolution of galactorrhea 
 MRI and visual field check up shoukd be done 6 monthly to reduce the 
tumour size. 
Drugs used : bromocriptine and cabergoline‖ 
Pregnancy and prolactin : 
The size of pituitary increases with pregnancy due to stimulatory effects 
of oestrogen.  bromocriptine is used safely in pregnancy without any 
tetratogenic side effects.  
For women taking bromocripitine desire pregnancy, mechanical 
contraception should be used for three regular menstrual cycles to allow for 
conception timing. 
Cabergoline is a long acting with high D2 receptor affinity .it is not 
recommended for use in women whose fertility is desired.  
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“CHILD PUGH SCORE: 
 It is a reasonably reliable predictor of survival in many liver diseases. It 
helps in predicting the complications of liver diseases like cirrhosis, 
oesophageal varices  and spontaneous bacterial peritonitis.  
Cirrhosis can be staged according to the scoring system. 
Cirrhosis can be staged clinically. A reliable scoring system is the 
modified CHILD PUGH scoring system. It ranges from 5 to 15.  
Child Pugh CLASS A : Score of 5 and 6 , consistent with compensated 
cirrhosis. 
Child Pugh CLASS B : Score of 7 to 9 , consistent with decompensated 
cirrhosis. 
Child Pugh CLASS C :Score more than 10 , consistent with 
decompensated cirrhosis. 
This scoring system includes 5 factors : serum bilirubin, serum albumin, 
ascites, hepatic encephalopathy and prothrombin time. It is reasonably a 
reliable predictor of survival and predicts the likelihood of major complications 
like bleeding from the varices and spontaneous bacterial peritonitis.It was also 
used to assess the prognosis in cirrhosis and to provide a standard criteria in 
listing the patient for liver transplantation. 
Thus comparing the serum prolactin level with the Child pugh scoring 
system in assessing the severity of the liver disease and predicting the risk of 
complications. 
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“Hepatic encephalopathy: 
 In patients with cirrhosis, there is a wide range of neuropsychiatric 
abnormalities ranging from clinically indescrinible changes in cognition to 
obvious changes in the intellect,behaviour ,motor function and consciousness. 
It has a detrimental effect on the survival of the patient. 
 Both hepatocellular failure and portosystemic shunt plays a vital role in 
the development of hepatic encephalopathy. Cirrhosis is the most common 
cause of hepatic encephalopathy. Gut derived neurotoxins predominantly 
ammonia, escape hepatic detoxification and impinge in the brain, there 
ammonia is detoxified by astrocytes ; leading to low grade cerebral edema and 
impairs the neuronal function. 
Classification of hepatic encephalopathy: 
 Overt hepatic encephalopathy 
 Episodic hepatic encephalopathy 
 Persistent hepatic encephalopathy 
 Minimal hepatic encephalopathy 
Overt Hepatic Encephalopathy: 
 It may arise over a period of hours or days in patient who has been 
previously stable, occurs intermittently and more frequently. There is a 
normalcy period between the episodes. Personality changes include 
childishness, irritability and loss of concern for family members. Intellectual 
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deterioration varies from mid confusion to gross disorientation ; visual spatial 
agnosia ;constructional apraxia  and writing becomes indistinct. 
Reduction of spontaneous movement ; fixed stare ,apathy and slowness 
and brevity of responses . Day time sleepiness is the earliest feature to detect 
hepatic encephalopathy, sometime it progress to delirium 
Changes in motor function : rigidity and disorders of speech production, 
tremors ,astrexis, hyper or hyporeflexia , choreo athetoid movements, Babinsky 
sign and transient focal symptoms. Astrexis is caused by impaired inflow of 
joint and other afferent information to the brainstem reticular formation .the 
tremors are absent at rest , less marked on movement and maximum on 
sustained posture. These movements also see in arms, jaw, neck , protruded 
tongue and tightly closed eyelids and ataxic gait. A flapping tremor also called 
Liver palms seen in heart failure , renal failure ,severe heart failure 
,hypomagnesemia and phenytoin intoxication 
Speech become monotonus and slurred. Deep tendon reflexes are 
exaggerated .Increased muscle tone leading to exaggeration of reflexes and 
plantar become flexor and extensor in deep stages of coma.  
Excessive appetite, muscle twitching, grasping and sucking reflex 
present Visual disturbance like reversible cortical blindness and alternating 
gaze deviation present. 
EPISODIC HEPATIC ENCEPHALOPATHY: 
It present in patients who are clinically stable.  
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PERSISTENT HEPATIC ENCEPHALOPATHY: 
 It presents as worsening of predominant clinical features rather than 
change in conscious level.  
There will be predominance of Parkinson features ;cerebellar signs and 
choreoathetoid movements 
MINIMAL HEPATIC ENCEPHALOPATHY: 
Patients presents with abnormalities in cognition and neurophysiological 
variables but patient is clinically stable. 
Hepatic myelopathy: 
 Patient presents with progressive spastic paraparesis without sensory 
impairement or spintcher dysfunction. It is due to degeneration of spinal cord. 
Neurological Examination: 
1. Higher mental status should be examined. 
2. Grading system is used to assess the mental status  West Haven criteria 
and Glasgow Coma scale is used for assessing the mental status. 
3. Psychometric analysis has to be done 
 Number Connection tests A AND B 
 Line tracing 
 Serial dotting 
 Digital symbol tests 
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4. Psychometric hepatic encephalopathy score has given to predict the 
clinical state of the patient. 
 EEG: shows progressive slowing of the alpha waves; and slowing of 
delta waves. 
 Triphasic waves present in severe encephalopathy. 
 Evoked potentials; smooth pursuit eye movements are used as 
neurophysiological tests. 
 Functional and cerebral imaging :  
 Cerebral and cerebellar atrophy 
 Hyperintensity in MRI : due to deposition of manganese reflects pallidal 
deposition. 
 Total body manganese is increased :  impaired biliary excretion; hepatic 
failure and the presence of portosystemic shunting of blood. 
 CEREBRAL MR Spectroscopy: reflects the cerebral metabolic process ; 
it is due to reduction in the myoinositol and choline resonance and 
increase in excitatory neurotransmitters. 
 Radiotracer imaging like SPECT AND PET are used 
 Blood ammonia increased and serum zinc level decreaed in patients with 
hepatic encephalopathy. 
 CSF glutamine concentration is useful in assessing the severity of 
hepatic encephalopathy. 
 Hepatic encephalopathy:pathogenesis 
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Two key factors in the development of encephalopathy are 
hepatocellular failure and porto systemic shunting. 
1. Gut derived neurotoxins 
2. Brain water homeostasis 
3. Oxidative /nitrosative stress 
4. Astrocyte dysfunction 
5. Alterations in cerebral neurotransmission. 
Consequences of Astrocyte swelling: 
1. Activation of extracellular regulated protein kinases 
2. Activation of NMDA receptors 
3. Upregulation of peripheral Benzodiazepene receptors 
4. Modulation of amino acid transport 
5. Modulation of multiple ion channels 
6. Induction of oxidative and nitrosative stress 
7. Increased ph in the endocytotic vesicles 
8. Alteration in cerebral neurotransmission 
9. Finally leading to neuronal dysfunction 
Alteration in cerebral neurotransmission: 
 Increase  in GABAergic transmission 
 Decrease in glutaminergic pathway 
 Increased synthesis of neurosteroids 
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 Serotonin and Dopamine level is decreased due to increased 
metabolism of monoamine oxidase A and increase in number of 
receptors 
 Dopamine level is decreased due to increased metabolism and increased 
concentration of Homovanillic acid in the urine 
 Extra pyramidal features are present in encephalopathy 
 Acetylcholine levels are reduced and rivastigmine gives a cognitive 
betterment. 
 Adenosine further aggravates the excitatory and inhibitory 
neurotransmitter imbalance 
Factors precipitating hepatic encephalopathy: 
 Gastrointestinal bleeding 
 Sepsis  
 Electrolyte imbalance : hyponatremia; hypokalemia 
 Starvation 
 Dehydration 
 Constipation  
 Excess protein load 
 Alcohol misuse 
 TIPS INSERTION, surgery‖ 
“HORMONAL CHANGES IN CIRRHOSIS: 
In cirrhosis, adrenal insufficiency occurs by number of mechanisms, 
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1. Low level of HDL Cholesterol 
2. Negative effect of cytokines on hypothalamus 
3. Increased conversion of cortisol to inactive cortisone 
Thyroid function in Cirrhosis of Liver: 
1. Thyroid dysfunction leading to decreased peripheral conversion of T4 to 
T3. Describing as ― low T3 Syndrome‖. 
2. It is completely reversible with liver transplantation 
Prolactin and Cirrhosis: 
 Normally prolactin is associated with characteristic nocturnal rise, and a 
characterisitic circadian rhythm. 
 Loss of circadian rhythm is characteristic of cirrhotic patients. 
 Suppression of hypothalamic pituitary axis. 
 Increased sex hormone binding globulin. 
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.MATERIALS AND METHODS 
STUDY POPULATION: 
SOURCE OF DATA: 
The study will be conducted on 100 patients admitted to 
Government Rajaji Hospital & Madurai Medical College during the study 
period from February 2017 to July  2017. 
Inclusion criteria: 
All patients with cirrhosis of liver. 
EXCLUSION CRITERIA:  
1. History of chest wall trauma 
2. Cranial surgery/ irradiation  
3.  Pituitary or hypothalamic disease  
4. Chronic renal failure 
5. Herpes zoster 
6. Seizure disorder 
7. Patient on medications known to elevate prolactin level. 
ANTICIPATED OUTCOME: 
Serum prolactin levels were elevated in cirrhosis patients with higher 
child pugh class, as well as in the complications thus making it a useful 
biomarker for severity of the disease and predicting the risk of complications. 
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DATA COLLECTION 
Informed consent will be obtained from all patients to be enrolled for 
the study. In all the patients relevant information will be collected in a 
predesigned proforma..The patients are selected based on clinical 
examinations, biochemical tests and ultrasound abdomen. Patients were 
subjected to routine cirrhosis work up. In  all cirrhotic patients serum 
prolactin level is measured and it is correlated with Child Pugh score in 
assessing the disease severity and the risk of compilcations. 
LABORATORY INVESTIGATIONS 
a) Complete blood count, 
b) Liver function test, 
c) Renal function test, 
d) Urine routine, 
e) Serum electrolytes and serum prolactin level 
f) HBsAg, 
g) HCV, 
h) Prothrombin time, aPTT and INR 
i) Electrocardiogram, 
j) Echo 
k) Chest X ray, 
l) USG abdomen 
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DESIGN OF STUDY:Prospective study. 
PERIOD OF STUDY:6 MONTHS (February 2017 to July 2017) 
COLLABORATING DEPARTMENTS: 
 DEPARTMENT OF MEDICAL GASTROENTEROLOGY 
 DEPARTMENT OF ENDOCRINOLOGY 
 DEPARTMENT OF BIOCHEMISTRY 
 DEPARTMENT OF RADIOLOGY                                                 
ETHICAL CLEARANCE: Clearance obtained 
CONSENT: Individual written and informed consent obtained. 
 CONFLICT OF INTEREST : NIL 
 FINANCIAL SUPPORT : SELF 
STATISTICAL ANALYSIS:  
All data were entered in Excel 2007 and statistical analysis was 
performed using the statistical software SPSS 16.0.Data were expressed as 
frequency (with percentages), median values (with range (min, max)). For 
continuous variables, Mann Whitney U-test was performed to find the 
differences between two groups and for categorical variables Pearson‘s chi-
square test was performed.Results were defined as statistically significant 
when the P value (2-sided) was less than 0.05 
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OBSERVATION AND RESULTS 
1.AGE DISTRIBUTION: 
TABLE 1 AND 2: AGE DISTRIBUTION AMONG PATIENTS 
PRESENTING WITH CIRRHOSIS OF LIVER 
Age (in yrs) 
N 50 
Mean 45.8 
SD 11.7 
Minimum 26 
Maximum 70 
 
Age group (in yrs) n (%) 
21 – 30   4 (8.0) 
31 – 40 16 (32.0) 
41 – 50  11 (22.0) 
51 – 60  13 (26.0) 
61 – 70  6 (12.0) 
Total 50 (100.0) 
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FIG 1: BAR DIAGRAM SHOWING THE AGE DISTRIBUTION OF 
LIVER FAILURE PATIENTS 
 
Comment : More people are in the age group of 31 to 40 yrs. 
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1.Gender distribution: 
Table 2 : Gender distribution in patients presenting with cirrhosis of liver 
Gender n (%) 
Male 32 (64.0) 
Female 18 (36.0) 
Total 50 (100.0) 
 
FIG 2:  PIE CHART SHOWING THE GENDER DISTRIBUTION OF 
CIRRHOTIC PATIENTS 
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3. ETIOLOGICAL CLASSIFICATION: 
TABLE  3: ETIOLOGICAL CLASSIFICATION OF CIRRHOSIS OF 
LIVER 
Etiology n (%) 
Alcohol 22 (44.0) 
Hepatitis B 8 (16.0) 
Hepatitis C 4 (8.0) 
Alcohol + Hepatitis B 3 (6.0) 
Alcohol + Hepatitis C 3 (6.0) 
Others 10 (20.0) 
Total 50 (100.0) 
 
FIG 3: ETIOLOGICAL CLASSIFICATION OF CIRRHOSIS 
 
4. SEVERITY OF ASCITES IN STUDY POPULATION: 
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FIG 4 : SEVERITY OF ASCITES IN STUDY POPULATION 
 
TABLE 4 : SEVERITY OF ASCITES IN STUDY POPULATION: 
Ascites n (%) 
Nil 20 (40.0) 
Mild 16 (32.0) 
Massive 14 (28.0) 
Total 50 (100.0) 
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5. GRADING OF ENCEPHALOPATHY: 
FIG 5: GRADING OF ENCEPHALOPATHY IN CIRRHOTIC 
PATIENTS 
 
TABLE 5 : GRADING OF ENCEPHALOPATHY IN STUDY 
POPULATION 
Encephalopathy Grading n (%) 
Nil 26 (52.0) 
Grade I 4 (8.0) 
Grade II 7 (14.0) 
Grade III 7 (14.0) 
Grade IV 6 (12.0) 
Total 50 (100.0) 
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6. GRADING OF VARICES IN STUDY POPULATION 
FIG 6: DIAGRAM PREDICTING THE VARICEAL GRADING IN 
ENCEPHALOPATHY 
 
Varices Grading n (%) 
Nil 22 (44.0) 
Grade I 3 (6.0) 
Grade II 9 (18.0) 
Grade III 10 (20.0) 
Grade IV 6 (12.0) 
Total 50 (100.0) 
 
TABLE 6 : VARICEAL GRADING IN STUDY POPULATION  
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7.CORRELATION OF PROLACTIN VALUE WITH VARICEAL 
GRADING 
TABLE 7 : CORRELATION OF SERUM PROLACTIN LEVEL WITH 
SEVERITY OF VARICES 
 
TABLE 7: CORRELATION OF SERUM PROLACTIN LEVEL WITH  
SEVERITY OF VARICES 
 
Varices Grading 
 
Grade I (n=3) Grade II (n=9) 
Grade III 
(n=10) 
Grade IV (n=6) 
 
Median (IQR) Median (IQR) Median (IQR) Median (IQR) 
Prolactin 24.0 (8.0, 40.0) 
47.1 (31.1, 
60.3) 
55.0 (47.7, 
59.2) 
58.5 (54.5, 
61.7) 
p-value 0.043 (Significant) 
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8.HEPATIC ENCEPHALOPATHY 
TABLE 8: PATIENTS PRESENTING WITH AND WITHOUT HEPATIC 
ENCEPHALOPATHY 
 Encephalopathy 
 
Without Encephalopathy 
(n=26) 
With Encephalopathy 
(n=24) 
 
Median (IQR) Median (IQR) 
Prolactin 8.6 (7.9, 14.0) 56.5 (47.3, 59.9) 
p-value <0.001 (Significant) 
 
 
FIG 8: SHOWING THE CORRELATION OF SERUM PROLACTIN 
VALUE WITH HEPATIC ENCEPHALOPATHY 
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9.CHILD PUGH SCORE TO PROLACTIN 
TAB 9 : CORRELATION OF SERUM PROLACTIN TO CHILD PUGH 
SCORE 
 
Mean 
Standard 
Deviation 
Correlation  
Co-efficient 
p-value 
Child Pugh-
Score 
9.32 3.5 
0.930 
<0.001 
(Significant) 
Prolactin 33.3 22.7 
 
FIG 9  : DIAGRAM SHOWING CORRELATION OF PROLACITN 
WITH CHILD PUGH SCORE 
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 Child Pugh/Class 
 
A (n=19) B (n=7) C (n=24) 
 
Median 
(IQR) 
 IQR) 
Median 
(IQR) 
Prolactin 8.0 (7.0, 9.7) 
26.1 (20.2, 
33.0) 
57.0 (48.5, 
60.0) 
p-value <0.001 (Significant) 
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DISCUSSION 
Prolactin level in hepatic dysfunction is always controversial. 
Among the neurotransmitter alteration, the principal one to be 
documented was dopamine. Dopamine is limited by the fact that it cannot be 
measured in any of the body fluids or brain. Since dopamine exerts negative 
control over prolactin, few studies from the west have shown prolactin to be a 
prognostic marker.[1,2] 
Elevation of prolactin is attributed mainly to the fall in dopamine levels 
in the 
tuberoinfundibular tract. Hormonal disturbance in cirrhosis has been evaluated 
by few researchers, and the studies have established lower T3 and cortisol 
levels with raised prolactin in the serum.[3] Decompensated liver function 
leads to an alteration in the type of amino acids entering the central nervous 
system. Circulating concentrations of aromatic amino acids have been found to 
increase leading to an increase in the synthesis of false neurotransmitters such 
as octopamine and phenylethanolamine.[8] 
 In our study population of 50 cirrhotic patients of various etiologies, 
Alcohol tops the list in males with most of them are in the age group of  31 to 
40 years. , while in females viral etiologies play an important role. 
 On comparing the Prolactin level, with the various complications of 
chronic liver disease like Ascites , oesophageal varices and hepatic 
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encephalopathy we are able to find a significant correlation with the severity of 
the disease.  
 The mean prolactin value found to be 56ng/ml in patients with massive 
ascites ; and in patients with grade 3 or 4 varices it is found to be around 55 
ng/ml and 58 ng/ml respectively. Thus it has better correlation with severity of 
disease in our study population. A similar correlation of mortality to serum 
prolactin levels was observed by McClain et al.[10] and Sharma et al.[11] with 
a higher risk of mortality with serum prolactin values of >50 ng/ml.   
    Prolactin release in human beings is normally associated with a 
pulsatile pattern, but a constant 24 h elevation has been found in patients with 
cirrhosis liver.[3] Cases of hypogonadism have also been reported in patients 
with cirrhosis attributing to hyperprolactinemia.[4]  
Although few researchers have associated the levels of prolactin with 
Child–Pugh‘s category of cirrhosis patients,the present study had few patient 
numbers in each of the categories ,the prolactin value found to be significantly 
correlate with the CHILD PUGH CLASS in assessing the severity of the 
disease. 
Mean prolactin value was found to be ,  8.0, 26 and  56 ng/ml in Child 
Pugh Class A ,B and C found to be increasing correlating with the severity of 
the disease. 
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Mukherjee et al.[12] analyzed the prolactin levels in patients with 
hepatic cirrhosis and found a higher levels in patients with encephalopathy and 
mortality.  
In patients with and without encephalopathy, mean prolactin value 
found to be 56ng/ml and 8ng/ml .Thus prolactin level founds to be significantly 
correlated with the patients having encephalopathy. Also, the authors found out 
a direct correlation between the clinico‑biochemical severities of the condition 
and mortality. They also found out a cut‑off level of 50 ng/ml of prolactin to 
predict the mortality, Koller et al.[4]. 
Thus prolactin level not only help in assessing the severity of the disease 
, it also helps in predicting the complications at an earlier stage of the disease 
process.  
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CONCLUSION 
 Prolactin level rises in hepatic cirrhosis ,with the loss of normal 
circadian rhythm. Since  the dopamine level cannot be directly measured in 
the body fluids , we used prolactin to measure the severity of the liver 
disease, as it is normally kept under the check of dopamine .Prolactin level 
significantly correlates with severity of the liver disease and predicting the 
risk of complications and helpful in preventing them. The rise in prolactin 
level also had a synonymous relationship with the Child Pugh Scoring 
system thus validating the use of Prolactin as a prognostic marker in hepatic 
cirrhosis. 
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PROFORMA 
Name: 
Age / Sex: 
Occupation: 
Presenting complaints: 
Past History: 
H/o DM, HT, CKD, CVD, DRUG INTAKE, CAD, Thyroid disorders, 
Alcohol intake 
Clinical Examination: 
General Examination: 
Consciousness,  
Pallor,  
Jaundice,  
Clubbing,  
Lymphadenopathy,  
Hydration status 
Vitals: 
PR 
 
 
BP 
RR 
SpO2 
Systemic examination: 
CVS: 
RS: 
ABDOMEN: 
CNS: 
Laboratory investigations: 
a) Complete blood count 
b) Renal function test 
c) Liver function test 
d) Urine routine 
e) Serum electrolyte 
f) HBsAg 
g) HCV 
h) Prothrombin time ,aPTT and INR 
 
 
i) Serum prolactin 
j) Electrocardiogram 
k) Echo  
l) Chest X ray 
m) USG abdomen          
 
 
 


